176 related articles for article (PubMed ID: 21376373)
21. A carbon monoxide-releasing molecule (CORM-3) uncouples mitochondrial respiration and modulates the production of reactive oxygen species.
Lo Iacono L; Boczkowski J; Zini R; Salouage I; Berdeaux A; Motterlini R; Morin D
Free Radic Biol Med; 2011 Jun; 50(11):1556-64. PubMed ID: 21382478
[TBL] [Abstract][Full Text] [Related]
22. A noble function of BAY 11-7082: Inhibition of platelet aggregation mediated by an elevated cAMP-induced VASP, and decreased ERK2/JNK1 phosphorylations.
Lee HS; Kim SD; Lee WM; Endale M; Kamruzzaman SM; Oh WJ; Cho JY; Kim SK; Cho HJ; Park HJ; Rhee MH
Eur J Pharmacol; 2010 Feb; 627(1-3):85-91. PubMed ID: 19913011
[TBL] [Abstract][Full Text] [Related]
23. Oxidative gastric mucosal damage induced by ischemia/reperfusion and the mechanisms of its prevention by carbon monoxide-releasing tricarbonyldichlororuthenium (II) dimer.
Magierowska K; Korbut E; Hubalewska-Mazgaj M; Surmiak M; Chmura A; Bakalarz D; Buszewicz G; Wójcik D; Śliwowski Z; Ginter G; Gromowski T; Kwiecień S; Brzozowski T; Magierowski M
Free Radic Biol Med; 2019 Dec; 145():198-208. PubMed ID: 31568823
[TBL] [Abstract][Full Text] [Related]
24. Potent antiplatelet activity of sesamol in an in vitro and in vivo model: pivotal roles of cyclic AMP and p38 mitogen-activated protein kinase.
Chang CC; Lu WJ; Chiang CW; Jayakumar T; Ong ET; Hsiao G; Fong TH; Chou DS; Sheu JR
J Nutr Biochem; 2010 Dec; 21(12):1214-21. PubMed ID: 20015631
[TBL] [Abstract][Full Text] [Related]
25. Antiplatelet Effect of Carbon Monoxide Is Mediated by NAD
Kaczara P; Sitek B; Przyborowski K; Kurpinska A; Kus K; Stojak M; Chlopicki S
Arterioscler Thromb Vasc Biol; 2020 Oct; 40(10):2376-2390. PubMed ID: 32787519
[TBL] [Abstract][Full Text] [Related]
26. Vasoactive properties of CORM-3, a novel water-soluble carbon monoxide-releasing molecule.
Foresti R; Hammad J; Clark JE; Johnson TR; Mann BE; Friebe A; Green CJ; Motterlini R
Br J Pharmacol; 2004 Jun; 142(3):453-60. PubMed ID: 15148243
[TBL] [Abstract][Full Text] [Related]
27. Carbon monoxide releasing molecule-2 enhances α2-antiplasmin activity.
Malayaman SN; Cohen JB; Machovec KA; Bernhardt BE; Arkebauer MR; Nielsen VG
Blood Coagul Fibrinolysis; 2011 Jun; 22(4):345-8. PubMed ID: 21330914
[TBL] [Abstract][Full Text] [Related]
28. [Molecular mechanism of inhibition of early pulmonary injury and inflammatory response by exogenous carbon monoxide: experiment with mice].
Sun BW; Chen X; Chen ZY; Katada K; Cepinskas G
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(44):3148-51. PubMed ID: 18269877
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of platelet aggregation by carbon monoxide is mediated by activation of guanylate cyclase.
Brüne B; Ullrich V
Mol Pharmacol; 1987 Oct; 32(4):497-504. PubMed ID: 2890093
[TBL] [Abstract][Full Text] [Related]
30. Adenosine-mediated inhibition of platelet aggregation by acadesine. A novel antithrombotic mechanism in vitro and in vivo.
Bullough DA; Zhang C; Montag A; Mullane KM; Young MA
J Clin Invest; 1994 Oct; 94(4):1524-32. PubMed ID: 7929829
[TBL] [Abstract][Full Text] [Related]
31. CO liberated from a carbon monoxide-releasing molecule exerts a positive inotropic effect in doxorubicin-induced cardiomyopathy.
Musameh MD; Green CJ; Mann BE; Motterlini R; Fuller BJ
J Cardiovasc Pharmacol; 2010 Feb; 55(2):168-75. PubMed ID: 19935076
[TBL] [Abstract][Full Text] [Related]
32. Carbon monoxide-releasing molecule-2 decreases fibrinolysis in vitro and in vivo in the rabbit.
Nielsen VG; Arkebauer MR; Wasko KA; Malayaman SN; Vosseller K
Blood Coagul Fibrinolysis; 2012 Jan; 23(1):104-7. PubMed ID: 22143252
[TBL] [Abstract][Full Text] [Related]
33. [Suppressive effect of exogenous carbon monoxide on abnormal platelet exocytosis and its molecular mechanism in sepsis].
Liu D; Xu X; Zhuang M; Song M; Qin W; Wang X; Sun B
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2016 Feb; 28(2):110-6. PubMed ID: 26911941
[TBL] [Abstract][Full Text] [Related]
34. The antifibrinolytic effects of carbon monoxide-releasing molecule-2 are fibrin and alpha2-antiplasmin dependent.
Nielsen VG
Blood Coagul Fibrinolysis; 2010 Sep; 21(6):584-7. PubMed ID: 20683324
[TBL] [Abstract][Full Text] [Related]
35. Regulation of PAI-1 concentration in platelets by systemic administration of antisense oligonucleotides to rats.
Pawlowska Z; Chabielska E; Kobylanska A; Maciaszek A; Swiatkowska M; Buczko W; Stec WJ; Cierniewski CS
Thromb Haemost; 2001 Jun; 85(6):1086-9. PubMed ID: 11434689
[TBL] [Abstract][Full Text] [Related]
36. Antithrombotic effects of MK-0852, a platelet fibrinogen receptor antagonist, in canine models of thrombosis.
Ramjit DR; Lynch JJ; Sitko GR; Mellott MJ; Holahan MA; Stabilito II; Stranieri MT; Zhang G; Lynch RJ; Manno PD
J Pharmacol Exp Ther; 1993 Sep; 266(3):1501-11. PubMed ID: 8371153
[TBL] [Abstract][Full Text] [Related]
37. Carbon monoxide-releasing molecule-2 decreases fibrinolysis in human plasma.
Nielsen VG; Kirklin JK; George JF
Blood Coagul Fibrinolysis; 2009 Sep; 20(6):448-55. PubMed ID: 19581800
[TBL] [Abstract][Full Text] [Related]
38. Carbon monoxide releasing molecule-2 increases the velocity of thrombus growth and strength in human plasma.
Nielsen VG; Kirklin JK; George JF
Blood Coagul Fibrinolysis; 2009 Jul; 20(5):377-80. PubMed ID: 19417630
[TBL] [Abstract][Full Text] [Related]
39. Aqueous extracts of Ocimum basilicum L. (sweet basil) decrease platelet aggregation induced by ADP and thrombin in vitro and rats arterio--venous shunt thrombosis in vivo.
Tohti I; Tursun M; Umar A; Turdi S; Imin H; Moore N
Thromb Res; 2006; 118(6):733-9. PubMed ID: 16469363
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of AR-H067637, the active metabolite of the new direct thrombin inhibitor AZD0837, in models of venous and arterial thrombosis and bleeding in anaesthetised rats.
Pehrsson S; Johansson K; Kjaer M; Elg M
Thromb Haemost; 2010 Dec; 104(6):1242-9. PubMed ID: 20806126
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]